More than a decade ago, clinicians noted striking similarities between patients with ebola and those with bacterial sepsis. Two of them – Dr. David S. Fedson, a retired professor of medicine at UVA, and Dr. Steven M. Opal, a professor of medicine at Brown University – analyzed several studies that have shown that STATINS reduce viral replication in human diseases. They recommend FDA approved oral immunomodulary STATIN drugs which are directly available that can treat the symptoms of Ebola and cure patients.